UPDATED Apr 30, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$389.33 | -4.5% | 27.5% | US$2.9t | US$476.88 | PE33.6x | E12.7% | 0.8% | Software | ||
GOOGL | US$162.78 | 2.9% | 54.6% | US$2.0t | US$188.14 | PE24.4x | E12.0% | 0.5% | Media | ||
AMZN | US$175.00 | -2.5% | 68.9% | US$1.8t | US$210.96 | PE59.8x | E21.7% | n/a | Retail | ||
META | US$430.17 | -13.3% | 79.8% | US$1.1t | US$522.24 | PE23.8x | E12.2% | 0.5% | Media | ||
LLY | US$781.10 | 4.7% | 93.2% | US$703.6b | US$823.82 | PE134.3x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$790.00 | 0.9% | 59.3% | NT$20.5t | NT$912.98 | PE23.9x | E16.1% | 1.8% | Semiconductors | ||
AVGO | US$1,300.27 | 4.1% | 112.3% | US$602.6b | US$1,500.96 | PE52x | E23.4% | 1.6% | Semiconductors | ||
NOVO B | kr.897.70 | 2.2% | 59.8% | kr.4.0t | kr.904.20 | PE47.9x | E14.7% | 1.0% | Pharmaceuticals & Biotech | ||
JPM | US$191.74 | -0.2% | 38.0% | US$550.7b | US$206.49 | PB1.8x | E-1.4% | 2.4% | Banks | ||
WMT | US$59.35 | 0.4% | 17.8% | US$478.3b | US$65.08 | PE30.8x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$118.27 | -2.3% | 7.4% | US$466.3b | US$130.47 | PE14.2x | E1.7% | 3.2% | Energy | ||
UNH | US$483.70 | -0.5% | -2.0% | US$445.0b | US$567.36 | PE29x | E19.2% | 1.6% | Healthcare | ||
700 | HK$347.20 | 0.9% | 2.3% | HK$3.2t | HK$417.77 | PE26x | E15.0% | 1.0% | Media | ||
PG | US$163.20 | 1.1% | 4.3% | US$385.2b | US$170.26 | PE25.9x | E7.2% | 2.5% | Household | ||
A005930 | ₩77,500.00 | -1.4% | 18.5% | ₩516.3t | ₩102,486.49 | PE26.7x | E23.7% | 1.9% | Tech | ||
JNJ | US$144.59 | -3.3% | -12.4% | US$348.4b | US$173.60 | PE18.2x | E5.1% | 3.4% | Pharmaceuticals & Biotech | ||
HD | US$334.22 | -1.4% | 13.6% | US$331.2b | US$384.83 | PE21.9x | E4.2% | 2.7% | Retail | ||
MRK | US$129.22 | 1.8% | 9.6% | US$327.3b | US$140.93 | PE141.9x | E26.1% | 2.4% | Pharmaceuticals & Biotech | ||
COST | US$722.90 | 0.03% | 46.1% | US$320.6b | US$776.41 | PE47.2x | E7.5% | 0.6% | Consumer Retailing | ||
ORCL | US$113.75 | -1.2% | 20.0% | US$312.6b | US$137.02 | PE29.4x | E14.7% | 1.4% | Software | ||
CVX | US$161.27 | -1.0% | 0.8% | US$297.2b | US$182.16 | PE14.6x | E2.5% | 4.0% | Energy | ||
600519 | CN¥1,705.00 | 0.7% | -3.2% | CN¥2.1t | CN¥2,157.44 | PE27.5x | E12.7% | 2.9% | Food, Beverage & Tobacco | ||
BAC | US$37.01 | -3.5% | 31.4% | US$291.2b | US$39.90 | PB1.1x | E6.2% | 2.6% | Banks | ||
ABBV | US$162.64 | -4.1% | 7.3% | US$288.0b | US$182.65 | PE48.4x | E23.2% | 3.8% | Pharmaceuticals & Biotech |